V. Bourg

650 total citations
27 papers, 430 citations indexed

About

V. Bourg is a scholar working on Genetics, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, V. Bourg has authored 27 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Neurology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in V. Bourg's work include Glioma Diagnosis and Treatment (11 papers), Multiple Sclerosis Research Studies (7 papers) and Peripheral Neuropathies and Disorders (6 papers). V. Bourg is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Multiple Sclerosis Research Studies (7 papers) and Peripheral Neuropathies and Disorders (6 papers). V. Bourg collaborates with scholars based in France, Switzerland and Netherlands. V. Bourg's co-authors include Christine Lebrun‐Frénay, N. Tieulié, Pierre Thomas, S. Chanalet, M. Lonjon, Marc Frénay, P. Thomas, P. Paquis, R M Chichmanian and M. Chatel and has published in prestigious journals such as Neurology, Annals of Oncology and Neuro-Oncology.

In The Last Decade

V. Bourg

26 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Bourg France 10 197 173 129 90 62 27 430
Martyn Carey United Kingdom 9 156 0.8× 86 0.5× 74 0.6× 29 0.3× 73 1.2× 23 327
S. Lodrini Italy 13 155 0.8× 91 0.5× 50 0.4× 71 0.8× 130 2.1× 27 513
F. Imbesi Italy 10 142 0.7× 120 0.7× 41 0.3× 37 0.4× 30 0.5× 19 284
Torfinn Solgaard Norway 9 259 1.3× 141 0.8× 113 0.9× 68 0.8× 88 1.4× 14 442
Youichi ITOYAMA Japan 13 185 0.9× 376 2.2× 77 0.6× 18 0.2× 83 1.3× 38 624
James M. Drake Canada 9 361 1.8× 338 2.0× 61 0.5× 24 0.3× 117 1.9× 9 693
Chiara Bosa Italy 9 126 0.6× 60 0.3× 44 0.3× 43 0.5× 29 0.5× 16 241
Katherine Sear United States 7 103 0.5× 98 0.6× 67 0.5× 22 0.2× 29 0.5× 10 249
Erin Felton United States 9 248 1.3× 145 0.8× 89 0.7× 16 0.2× 86 1.4× 16 353
Riri S. Manor Israel 13 39 0.2× 100 0.6× 81 0.6× 24 0.3× 71 1.1× 41 515

Countries citing papers authored by V. Bourg

Since Specialization
Citations

This map shows the geographic impact of V. Bourg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Bourg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Bourg more than expected).

Fields of papers citing papers by V. Bourg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Bourg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Bourg. The network helps show where V. Bourg may publish in the future.

Co-authorship network of co-authors of V. Bourg

This figure shows the co-authorship network connecting the top 25 collaborators of V. Bourg. A scholar is included among the top collaborators of V. Bourg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Bourg. V. Bourg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saâda, Esma, Jocelyn Gal, Jean‐Sébastien Frenel, et al.. (2024). 62P Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed glioblastoma multiforme: PAZOGLIO trial. ESMO Open. 9. 102291–102291. 1 indexed citations
2.
Bourg, V., et al.. (2023). Functional and MRI results after a 7.5 year follow-up of 35 single-stage ACL and PCL reconstructions using gracilis and semitendinosus tendon grafts and LARS artificial ligaments. European Journal of Orthopaedic Surgery & Traumatology. 34(2). 1163–1172. 1 indexed citations
3.
Picart, Thiébaud, Marc Barritault, Delphine Poncet, et al.. (2022). Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. S196–S196. 1 indexed citations
4.
Vandenbos, F., V. Bourg, S. Chanalet, et al.. (2014). Impact de la TEP à la 18F-DOPA sur la décision thérapeutique en RCP lors du diagnostic différentiel entre radionécrose et récidive de néoplasie cérébrale. Médecine Nucléaire. 38(3). 132–133. 1 indexed citations
5.
Bourg, V., M. Frénay, Mikaël Cohen, et al.. (2011). Le bévacizumab dans le traitement des radionécroses cérébrales. Revue Neurologique. 167(4). 331–336. 10 indexed citations
6.
Rheims, Sylvain, Damien Ricard, Martin J. van den Bent, et al.. (2011). Peri-ictal pseudoprogression in patients with brain tumor. Neuro-Oncology. 13(7). 775–782. 24 indexed citations
7.
Lebrun‐Frénay, Christine, V. Bourg, N. Tieulié, & Pierre Thomas. (2008). Successful treatment of refractory generalized myasthenia gravis with rituximab. European Journal of Neurology. 16(2). 246–250. 82 indexed citations
8.
Lebrun‐Frénay, Christine, Denys Fontaine, V. Bourg, et al.. (2007). Treatment of newly diagnosed symptomatic pure low‐grade oligodendrogliomas with PCV chemotherapy. European Journal of Neurology. 14(4). 391–398. 43 indexed citations
9.
Jeannin, S., V. Bourg, F. Berthier, & Christine Lebrun‐Frénay. (2007). Caractéristiques phénotypiques et évolutives de la SEP chez des patients originaires du Maghreb et suivis au CHRU de Nice (à propos d’une cohorte de 76 patients). Revue Neurologique. 163(4). 440–447. 11 indexed citations
10.
Sédat, Jacques, Yves Chau, M.H. Mahagne, et al.. (2007). Dissection of the Posteroinferior Cerebellar Artery: Clinical Characteristics and Long-Term Follow-Up in Five Cases. Cerebrovascular Diseases. 24(2-3). 183–190. 33 indexed citations
11.
Chaussenot, Annabelle, et al.. (2007). Neurosarcoïdose et mycophénolate mofétil. Revue Neurologique. 163(4). 471–475. 20 indexed citations
12.
Jeannin, S., Christine Lebrun‐Frénay, Frederiek van den Bos, et al.. (2006). Syndrome de Turcot confirmé par biologie moléculaire. Revue Neurologique. 162(6-7). 741–746. 1 indexed citations
13.
Lebrun‐Frénay, Christine, H. Alchaar, M. Candito, V. Bourg, & M. Chatel. (2006). Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue. Multiple Sclerosis Journal. 12(3). 321–324. 29 indexed citations
14.
Lebrun‐Frénay, Christine, et al.. (2005). Sclérose en plaques rémittente ou encéphalomyélite multiphasique disséminée ?. Revue Neurologique. 161(2). 228–233. 2 indexed citations
15.
Bensa, Caroline, et al.. (2005). Méningite récurrente aseptique associée à une cirrhose biliaire primitive. Revue Neurologique. 161(1). 87–91.
16.
Lebrun‐Frénay, Christine, S. Chanalet, V. Bourg, et al.. (2004). Intérêt du recalage automatique des IRM cérébrales dans le suivi des scléroses en plaques. Revue Neurologique. 160(8-9). 805–810. 1 indexed citations
17.
Lebrun‐Frénay, Christine, et al.. (2004). Chimiothérapie néoadjuvante dans les astrocytomes fibrillaires de grade II symptomatiques non opérables de l’adulte. Revue Neurologique. 160(5). 533–537. 4 indexed citations
18.
Delmont, Émilien, S. Chanalet, V. Bourg, et al.. (2004). Association cyclophosphamide-méthylprednisolone en traitement de fond des scléroses en plaques de type progressif : facteurs prédictifs d’une réponse clinique. Revue Neurologique. 160(6-7). 659–665. 4 indexed citations
19.
Delmont, Émilien, M. Lonjon, Jean‐François Michiels, et al.. (2003). [Castleman's disease located in the central nervous system].. PubMed. 159(5 Pt 1). 581–5. 3 indexed citations
20.
Bourg, V., Christine Lebrun‐Frénay, R M Chichmanian, P. Thomas, & Marc Frénay. (2001). Nitroso-urea–cisplatin-based chemotherapy associated with valproate: Increase of haematologic toxicity. Annals of Oncology. 12(2). 217–220. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martyn Carey Breakdown of academic impact, for papers by S. Lodrini Breakdown of academic impact, for papers by F. Imbesi Breakdown of academic impact, for papers by Torfinn Solgaard Breakdown of academic impact, for papers by Youichi ITOYAMA Breakdown of academic impact, for papers by James M. Drake Breakdown of academic impact, for papers by Chiara Bosa Breakdown of academic impact, for papers by Katherine Sear Breakdown of academic impact, for papers by Erin Felton Breakdown of academic impact, for papers by Riri S. Manor
Rankless by CCL
2026